Exalenz Bioscience Appoints Roy Golan as President and Chief Financial Officer
Apr 30, 2018 11:30 am UTC| Business
Healthcare Industry Veteran Brings Track Record of Success MODI’IN, Israel and MANASQUAN, N.J., April 30, 2018 -- Exalenz Bioscience Ltd. (TASE:EXEN), a leader in developing and marketing non-invasive medical...
Apr 30, 2018 11:30 am UTC| Business
SAN DIEGO, April 30, 2018 -- Conatus Pharmaceuticals Inc. (Nasdaq:CNAT) today announced the completion of enrollment in ENCORE-PH, a Phase 2b clinical trial evaluating emricasan, the company’s first-in-class,...
Macatawa Bank Corporation Declares Quarterly Dividend
Apr 30, 2018 11:30 am UTC| Business
HOLLAND, Mich., April 30, 2018 -- Macatawa Bank Corporation (Nasdaq:MCBC) (the "Company" or "Macatawa") today announced that its Board of Directors has declared a quarterly cash dividend of $0.06 per share on its common...
Dried Spices Market: Supermarkets/Hypermarkets to Generate Significant Revenues
Apr 30, 2018 11:23 am UTC| Business
Rockville Pike, April 30, 2018 -- As the need to enhance flavor in food products continue to increase, manufacturers in the food industry are increasingly focusing on using dried spices as an important ingredient. Apart...
6 Key Takeaways from Fact.MR’s Report on Drip Coffee Machine Market for Forecast Period 2017-2026
Apr 30, 2018 11:18 am UTC| Business
Rockville Pike, April 30, 2018 -- A drip coffee machine is the most basic type of coffee machine used across the world. Most of the drip coffee machines have very few programmable features, but they are still easy to...
Clientless Remote Support Software Market: PC/Laptop Products to Generate Significant Revenues
Apr 30, 2018 11:08 am UTC| Business
Rockville Pike, April 30, 2018 -- Growing need to connect devices for offering customer support is projected to rev up demand for the clientless remote support software globally. As manufacturers are...
uniQure Announces First Quarter 2018 Financial Results and Highlights Company Progress
Apr 30, 2018 11:05 am UTC| Business
~ Patient enrollment expected to begin ahead of schedule in dose-confirmation study for AMT-061 and pivotal study on track to commence in third quarter of 2018 ~ IND filing for AMT-130 in Huntington’s Disease expected in...